Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Bone Grafts and Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036" report has been added to ...
Driven by an aging population and an expanding pool of younger patients, bone-graft substitutes are a $2.5 billion market, which should continue to rise as a result of minimally invasive procedures.
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global bone graft and substitutes market is estimated to be valued at US$ 3,046.7 million in 2019, and is expected to exhibit a ...
Molecular Matrix, a privately held company that arose from the University of California, Davis, received FDA approval for its Osteo-P bone graft substitute technology. Osteo-P is a non-mineralized, ...
Use of silicate-substituted calcium phosphate bone substitute had equivalent knee laxity and clinical function outcomes compared with autologous bone graft 3 years after two-stage ACL reconstruction, ...
Clinicians should avoid routine off-label use of certain bone graft substitutes in patients younger than 18 years of age with bone disorders because of the risk for serious injury, according to the ...
DUBLIN--(BUSINESS WIRE)--The "Bone Graft Substitutes: Global Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. This report provides separate ...
RESEARCH TRIANGLE PARK – Durham-based Bioventus, a global medtech company which went public earlier this year, is releasing a new product to its lineup that uses human tissue to improve bone fusions.
VANCOUVER, BRITISH COLUMBIA, CANADA, April 4, 2023/EINPresswire.com/ -- iData Research, a leading global consulting and market research firm, has published an ...
Please provide your email address to receive an email when new articles are posted on . Bonalive Biomaterials Ltd. has been granted FDA breakthrough device designation for its Bonalive orthopedics ...
SAN FRANCISCO, Feb. 19, 2020 /PRNewswire/ -- The global bone grafts & substitutes market size is expected to reach USD 3.54 billion by 2026, according to a new report by Grand View Research, Inc. The ...
RESEARCH TRIANGLE PARK – Durham-based Bioventus has come up with a new bone graft substitute that it says is easier for doctors to handle, promotes healing in patients, and provides potential cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results